These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31570655)

  • 1. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
    Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
    Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
    Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
    Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of notch signaling in osteosarcoma invasion and metastasis.
    Zhang P; Yang Y; Zweidler-McKay PA; Hughes DP
    Clin Cancer Res; 2008 May; 14(10):2962-9. PubMed ID: 18483362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
    Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
    Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
    Hughes DP
    Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
    Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
    Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
    Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
    BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
    Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
    BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway.
    Jin L; Vu T; Yuan G; Datta PK
    Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
    Li Z; Tang Y; Xing W; Dong W; Wang Z
    Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
    Yu L; Fan Z; Fang S; Yang J; Gao T; Simões BM; Eyre R; Guo W; Clarke RB
    Oncotarget; 2016 May; 7(22):33055-68. PubMed ID: 27102300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling.
    Li Y; Zhang J; Zhang L; Si M; Yin H; Li J
    Carcinogenesis; 2013 Jul; 34(7):1601-10. PubMed ID: 23430952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spindle and kinetochore-related complex subunit 3 has a protumour function in osteosarcoma by activating the Notch pathway.
    Liang G; Duan C; He J; Shi L
    Toxicol Appl Pharmacol; 2024 Feb; 483():116826. PubMed ID: 38228236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
    Zhao YY; Yu GT; Xiao T; Hu J
    Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway.
    Cheng J; Zhang Y; Wan R; Zhou J; Wu X; Fan Q; He J; Tan W; Deng Y
    Front Oncol; 2022; 12():919108. PubMed ID: 35957875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling.
    Li Y; Zhang J; Ma D; Zhang L; Si M; Yin H; Li J
    FEBS J; 2012 Jun; 279(12):2247-59. PubMed ID: 22521131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
    Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
    Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.